Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation.

Lysine acetylation of the tumor suppressor protein p53 in response to a wide variety of cellular stress signals is required for its activation as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis. Here, we report that the conserved bromo-domain of the transcriptional coactivator CBP (CREB binding protein) binds specifically to p53 at the C-terminal acetylated lysine 382. This bromodomain/acetyl-lysine binding is responsible for p53 acetylation-dependent coactivator recruitment after DNA damage, a step essential for p53-induced transcriptional activation of the cyclin-dependent kinase inhibitor p21 in G1 cell cycle arrest. We further present the three-dimensional nuclear magnetic resonance structure of the CBP bromodomain in complex with a lysine 382-acetylated p53 peptide. Using structural and biochemical analyses, we define the molecular determinants for the specificity of this molecular recognition.

[1]  Ettore Appella,et al.  p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2 , 2001, The EMBO journal.

[2]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[3]  S. Berger,et al.  Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. , 2001, Molecular cell.

[4]  J. T. Kadonaga,et al.  p300 Forms a Stable, Template-Committed Complex with Chromatin: Role for the Bromodomain , 2001, Molecular and Cellular Biology.

[5]  R. Tjian,et al.  Structure and function of a human TAFII250 double bromodomain module. , 2000, Science.

[6]  M. Cleary,et al.  Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins , 2001, Oncogene.

[7]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[8]  Yoshiharu Kawaguchi,et al.  MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.

[9]  Yuxin Yin,et al.  PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression , 2003, Nature.

[10]  Muyang Li,et al.  Acetylation of p53 Inhibits Its Ubiquitination by Mdm2* , 2002, The Journal of Biological Chemistry.

[11]  S. Berger,et al.  Structure and function of bromodomains in chromatin-regulating complexes. , 2001, Gene.

[12]  A. Travers,et al.  Chromatin modification: How to put a HAT on the histones , 1999, Current Biology.

[13]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[14]  Mike Carson,et al.  RIBBONS 2.0 , 1991 .

[15]  H. Dyson,et al.  Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. , 2000, Journal of molecular biology.

[16]  Antonio Giordano,et al.  p300 and CBP: Partners for life and death , 1999, Journal of cellular physiology.

[17]  Changchun Du,et al.  Chromatin‐related properties of CBP fused to MLL generate a myelodysplastic‐like syndrome that evolves into myeloid leukemia , 2000, The EMBO journal.

[18]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[19]  Weontae Lee,et al.  A Suite of Triple Resonance NMR Experiments for the Backbone Assignment of 15N, 13C, 2H Labeled Proteins with High Sensitivity , 1994 .

[20]  V. Fried,et al.  Stress-activated kinases regulate protein stability , 1998, Oncogene.

[21]  Lei Zeng,et al.  Structure and ligand of a histone acetyltransferase bromodomain , 1999, Nature.

[22]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[23]  J. Workman,et al.  Function and Selectivity of Bromodomains in Anchoring Chromatin-Modifying Complexes to Promoter Nucleosomes , 2002, Cell.

[24]  A. Gronenborn,et al.  Multidimensional heteronuclear nuclear magnetic resonance of proteins. , 1994, Methods in enzymology.

[25]  V. Kiermer,et al.  Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain , 2002, The EMBO journal.

[26]  P. Pearson,et al.  Atmospheric carbon dioxide concentrations over the past 60 million years , 2000, Nature.

[27]  S. Berger,et al.  CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. , 1997, Cancer research.

[28]  N. Zeleznik-Le,et al.  Retroviral transduction model of mixed lineage leukemia fused to CREB binding protein , 2001, Current opinion in hematology.

[29]  Eric Verdin,et al.  Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. , 2002, Molecular cell.

[30]  K. Kinzler,et al.  Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. , 1995, Cancer research.

[31]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[32]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[33]  J. Workman,et al.  Recruitment of HAT Complexes by Direct Activator Interactions with the ATM-Related Tra1 Subunit , 2001, Science.

[34]  D. Livingston,et al.  Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.

[35]  G. Zambetti,et al.  Mdm‐2: “big brother” of p53 , 1997, Journal of cellular biochemistry.

[36]  C. Allis,et al.  Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. , 1996, Current opinion in genetics & development.

[37]  Ailan Guo,et al.  The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.

[38]  K. Gardner,et al.  Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.

[39]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[40]  S. Davies,et al.  Big brother : Britain's web of surveillance and the new technological order , 1996 .

[41]  D. Lane,et al.  Allosteric activation of latent p53 tetramers , 1994, Current Biology.

[42]  H. Shih,et al.  Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP , 1996, Nature.

[43]  Z. Ronai,et al.  p53-Mdm2--the affair that never ends. , 2002, Carcinogenesis.

[44]  F. Jeanmougin,et al.  The bromodomain revisited. , 1997, Trends in biochemical sciences.

[45]  Pier Paolo Pandolfi,et al.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras , 2000, Nature.

[46]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[47]  S. Lowe,et al.  Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene‐mediated apoptosis. , 1996, The EMBO journal.

[48]  Michael Nilges,et al.  Ambiguous NOEs and automated NOE assignment , 1998 .

[49]  M. Pincus,et al.  MEKK1/JNK signaling stabilizes and activates p53. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Fred Winston,et al.  Functional Organization of the Yeast SAGA Complex: Distinct Components Involved in Structural Integrity, Nucleosome Acetylation, and TATA-Binding Protein Interaction , 1999, Molecular and Cellular Biology.

[51]  Fred Winston,et al.  The bromodomain: a chromatin-targeting module? , 1999, Nature Structural Biology.

[52]  D. Speicher,et al.  KAP-1, a novel corepressor for the highly conserved KRAB repression domain. , 1996, Genes & development.

[53]  Delin Chen,et al.  Deacetylation of p53 modulates its effect on cell growth and apoptosis , 2000, Nature.

[54]  C. Prives,et al.  Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.

[55]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[56]  Thomas C. Kaufman,et al.  brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2 SWI2 , 1992, Cell.

[57]  J. Roth,et al.  Multiple Lysine Mutations in the C-Terminal Domain of p53 Interfere with MDM2-Dependent Protein Degradation and Ubiquitination , 2000, Molecular and Cellular Biology.

[58]  S. Berger,et al.  p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage , 1999, Molecular and Cellular Biology.

[59]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[60]  P. Evans,et al.  The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p , 2000, The EMBO journal.

[61]  D. Housman,et al.  MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[62]  L. Donehower,et al.  The tumor suppressor p53. , 1993, Biochimica et biophysica acta.

[63]  Dimitris Thanos,et al.  Deciphering the Transcriptional Histone Acetylation Code for a Human Gene , 2002, Cell.

[64]  Ming-Ming Zhou,et al.  Bromodomain: an acetyl‐lysine binding domain , 2002, FEBS letters.

[65]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[66]  J. Manfredi,et al.  Constitutive Expression of the Cyclin-dependent Kinase Inhibitor p21 Is Transcriptionally Regulated by the Tumor Suppressor Protein p53* , 1998, The Journal of Biological Chemistry.

[67]  I B Dawid,et al.  The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins. , 1992, Nucleic acids research.

[68]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[69]  R. Goodman,et al.  CREB-binding Protein and p300 in Transcriptional Regulation* , 2001, The Journal of Biological Chemistry.

[70]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .